Cabergoline versus levodopa monotherapy.
Identifieur interne : 000E61 ( Ncbi/Curation ); précédent : 000E60; suivant : 000E62Cabergoline versus levodopa monotherapy.
Auteurs : Keith Wheatley ; Carl E. Clarke ; Natalie Ives ; Richard GraySource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.
English descriptors
- KwdEn :
- MESH :
- chemical , economics : Antiparkinson Agents, Ergolines, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Ergolines, Levodopa.
- drug therapy : Parkinson Disease.
- economics : Parkinson Disease.
- Cost-Benefit Analysis, Humans, Middle Aged.
DOI: 10.1002/mds.20032
PubMed: 15197724
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003423
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003423
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003537
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000E61
Links to Exploration step
pubmed:15197724Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cabergoline versus levodopa monotherapy.</title>
<author><name sortKey="Wheatley, Keith" sort="Wheatley, Keith" uniqKey="Wheatley K" first="Keith" last="Wheatley">Keith Wheatley</name>
</author>
<author><name sortKey="Clarke, Carl E" sort="Clarke, Carl E" uniqKey="Clarke C" first="Carl E" last="Clarke">Carl E. Clarke</name>
</author>
<author><name sortKey="Ives, Natalie" sort="Ives, Natalie" uniqKey="Ives N" first="Natalie" last="Ives">Natalie Ives</name>
</author>
<author><name sortKey="Gray, Richard" sort="Gray, Richard" uniqKey="Gray R" first="Richard" last="Gray">Richard Gray</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15197724</idno>
<idno type="pmid">15197724</idno>
<idno type="doi">10.1002/mds.20032</idno>
<idno type="wicri:Area/PubMed/Corpus">003423</idno>
<idno type="wicri:Area/PubMed/Curation">003423</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003537</idno>
<idno type="wicri:Area/Ncbi/Merge">000E61</idno>
<idno type="wicri:Area/Ncbi/Curation">000E61</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cabergoline versus levodopa monotherapy.</title>
<author><name sortKey="Wheatley, Keith" sort="Wheatley, Keith" uniqKey="Wheatley K" first="Keith" last="Wheatley">Keith Wheatley</name>
</author>
<author><name sortKey="Clarke, Carl E" sort="Clarke, Carl E" uniqKey="Clarke C" first="Carl E" last="Clarke">Carl E. Clarke</name>
</author>
<author><name sortKey="Ives, Natalie" sort="Ives, Natalie" uniqKey="Ives N" first="Natalie" last="Ives">Natalie Ives</name>
</author>
<author><name sortKey="Gray, Richard" sort="Gray, Richard" uniqKey="Gray R" first="Richard" last="Gray">Richard Gray</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (economics)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cost-Benefit Analysis</term>
<term>Ergolines (economics)</term>
<term>Ergolines (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (economics)</term>
<term>Levodopa (therapeutic use)</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (economics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Ergolines</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000E61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:15197724 |texte= Cabergoline versus levodopa monotherapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:15197724" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |